Applications submitted to the FY23 NFRP must address one or more of the following Areas of Emphasis:

• NF Type 2 and Schwannomatosis-related areas (e.g., hearing, balance, schwannoma, ependymoma, meningioma, LZTR1, SMARCB1)
• Endpoint validation, biomarker discovery, and technological innovation for assessments
• Application of data science
• Non-tumor manifestations not limited to:
• Pain
• Cognitive manifestations
• Sleep
• Heterogeneity of NF-related phenotypes
• Genetics, genomics, epigenetics, systems biology, metabolomics, or similar approaches
• Preclinical efficacy studies
• Target identification and drug discovery
• Nutritional, environmental, and other modifiers of NF
• Health services research

See all awards for this funding opportunity